Used in pharmaceutical synthesis as an intermediate for developing central nervous system (CNS) active compounds. Its structure supports the creation of selective receptor modulators, particularly in the development of antidepressants and anxiolytics. The amine group allows for salt formation to improve stability and bioavailability, while the cyclobutyl and methoxyphenyl moieties contribute to binding affinity and metabolic resistance. Also explored in medicinal chemistry for optimizing drug candidates targeting neurological disorders due to its conformational rigidity and favorable pharmacokinetic profile.